nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—Ca++ increased—Capecitabine—esophageal cancer	0.0524	0.0609	CcSEcCtD
Dexrazoxane—Sodium decreased—Capecitabine—esophageal cancer	0.0486	0.0565	CcSEcCtD
Dexrazoxane—Infusion site pain—Capecitabine—esophageal cancer	0.04	0.0466	CcSEcCtD
Dexrazoxane—Extravasation—Carboplatin—esophageal cancer	0.0348	0.0405	CcSEcCtD
Dexrazoxane—Phlebitis—Carboplatin—esophageal cancer	0.0256	0.0298	CcSEcCtD
Dexrazoxane—Neurotoxicity—Cisplatin—esophageal cancer	0.023	0.0267	CcSEcCtD
Dexrazoxane—TOP2B—bronchus—esophageal cancer	0.0223	0.16	CbGeAlD
Dexrazoxane—TOP2B—smooth muscle tissue—esophageal cancer	0.0218	0.156	CbGeAlD
Dexrazoxane—TOP2B—trachea—esophageal cancer	0.02	0.143	CbGeAlD
Dexrazoxane—Myelosuppression—Cisplatin—esophageal cancer	0.019	0.0221	CcSEcCtD
Dexrazoxane—TOP2B—digestive system—esophageal cancer	0.0172	0.123	CbGeAlD
Dexrazoxane—Neurotoxicity—Capecitabine—esophageal cancer	0.017	0.0197	CcSEcCtD
Dexrazoxane—TOP2A—bronchus—esophageal cancer	0.0164	0.117	CbGeAlD
Dexrazoxane—Febrile neutropenia—Cisplatin—esophageal cancer	0.0148	0.0172	CcSEcCtD
Dexrazoxane—TOP2B—lung—esophageal cancer	0.0144	0.103	CbGeAlD
Dexrazoxane—Neurotoxicity—Methotrexate—esophageal cancer	0.0126	0.0147	CcSEcCtD
Dexrazoxane—Platelet count decreased—Capecitabine—esophageal cancer	0.0111	0.0128	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Capecitabine—esophageal cancer	0.0109	0.0127	CcSEcCtD
Dexrazoxane—Infection—Carboplatin—esophageal cancer	0.0108	0.0125	CcSEcCtD
Dexrazoxane—TOP2A—lung—esophageal cancer	0.0106	0.0757	CbGeAlD
Dexrazoxane—Extravasation—Cisplatin—esophageal cancer	0.0102	0.0119	CcSEcCtD
Dexrazoxane—TOP2B—lymph node—esophageal cancer	0.00984	0.0704	CbGeAlD
Dexrazoxane—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00955	0.0111	CcSEcCtD
Dexrazoxane—Hypercalcaemia—Capecitabine—esophageal cancer	0.00946	0.011	CcSEcCtD
Dexrazoxane—Pain—Carboplatin—esophageal cancer	0.00927	0.0108	CcSEcCtD
Dexrazoxane—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00888	0.0103	CcSEcCtD
Dexrazoxane—Body temperature increased—Carboplatin—esophageal cancer	0.00857	0.00997	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Methotrexate—esophageal cancer	0.00813	0.00946	CcSEcCtD
Dexrazoxane—Injection site pain—Capecitabine—esophageal cancer	0.00805	0.00936	CcSEcCtD
Dexrazoxane—Phlebitis—Cisplatin—esophageal cancer	0.00751	0.00873	CcSEcCtD
Dexrazoxane—TOP2A—lymph node—esophageal cancer	0.00724	0.0518	CbGeAlD
Dexrazoxane—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00714	0.0083	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00695	0.00808	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00657	0.00764	CcSEcCtD
Dexrazoxane—Injection site reaction—Capecitabine—esophageal cancer	0.00653	0.0076	CcSEcCtD
Dexrazoxane—Hyponatraemia—Cisplatin—esophageal cancer	0.0065	0.00756	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Cisplatin—esophageal cancer	0.00606	0.00705	CcSEcCtD
Dexrazoxane—Oesophagitis—Capecitabine—esophageal cancer	0.00601	0.00698	CcSEcCtD
Dexrazoxane—Breast disorder—Cisplatin—esophageal cancer	0.00585	0.0068	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00583	0.00678	CcSEcCtD
Dexrazoxane—Sepsis—Capecitabine—esophageal cancer	0.0057	0.00663	CcSEcCtD
Dexrazoxane—Extravasation—Methotrexate—esophageal cancer	0.00561	0.00652	CcSEcCtD
Dexrazoxane—Phlebitis—Capecitabine—esophageal cancer	0.00554	0.00644	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00549	0.00638	CcSEcCtD
Dexrazoxane—Pancytopenia—Cisplatin—esophageal cancer	0.00531	0.00618	CcSEcCtD
Dexrazoxane—Stomatitis—Cisplatin—esophageal cancer	0.00486	0.00565	CcSEcCtD
Dexrazoxane—Hyponatraemia—Capecitabine—esophageal cancer	0.00479	0.00557	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Capecitabine—esophageal cancer	0.00447	0.0052	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Cisplatin—esophageal cancer	0.0044	0.00512	CcSEcCtD
Dexrazoxane—Breast disorder—Capecitabine—esophageal cancer	0.00431	0.00501	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.0043	0.005	CcSEcCtD
Dexrazoxane—Sepsis—Methotrexate—esophageal cancer	0.00425	0.00494	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00421	0.00489	CcSEcCtD
Dexrazoxane—Cardiac disorder—Cisplatin—esophageal cancer	0.00416	0.00483	CcSEcCtD
Dexrazoxane—Dysphagia—Capecitabine—esophageal cancer	0.00412	0.00479	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Cisplatin—esophageal cancer	0.00404	0.00469	CcSEcCtD
Dexrazoxane—Alopecia—Cisplatin—esophageal cancer	0.00396	0.0046	CcSEcCtD
Dexrazoxane—Pancytopenia—Capecitabine—esophageal cancer	0.00392	0.00455	CcSEcCtD
Dexrazoxane—Erythema—Cisplatin—esophageal cancer	0.0039	0.00453	CcSEcCtD
Dexrazoxane—Malnutrition—Cisplatin—esophageal cancer	0.0039	0.00453	CcSEcCtD
Dexrazoxane—Neutropenia—Capecitabine—esophageal cancer	0.00386	0.00448	CcSEcCtD
Dexrazoxane—Weight decreased—Capecitabine—esophageal cancer	0.00373	0.00434	CcSEcCtD
Dexrazoxane—Pneumonia—Capecitabine—esophageal cancer	0.0037	0.0043	CcSEcCtD
Dexrazoxane—Infestation—Capecitabine—esophageal cancer	0.00368	0.00427	CcSEcCtD
Dexrazoxane—Infestation NOS—Capecitabine—esophageal cancer	0.00368	0.00427	CcSEcCtD
Dexrazoxane—Depression—Capecitabine—esophageal cancer	0.00367	0.00426	CcSEcCtD
Dexrazoxane—Tremor—Cisplatin—esophageal cancer	0.00365	0.00425	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Cisplatin—esophageal cancer	0.00362	0.0042	CcSEcCtD
Dexrazoxane—Anaemia—Cisplatin—esophageal cancer	0.0036	0.00419	CcSEcCtD
Dexrazoxane—Stomatitis—Capecitabine—esophageal cancer	0.00358	0.00417	CcSEcCtD
Dexrazoxane—Malaise—Cisplatin—esophageal cancer	0.00352	0.00409	CcSEcCtD
Dexrazoxane—Leukopenia—Cisplatin—esophageal cancer	0.00349	0.00406	CcSEcCtD
Dexrazoxane—Agranulocytosis—Capecitabine—esophageal cancer	0.00343	0.00399	CcSEcCtD
Dexrazoxane—Myalgia—Cisplatin—esophageal cancer	0.00332	0.00386	CcSEcCtD
Dexrazoxane—Haemoglobin—Capecitabine—esophageal cancer	0.00332	0.00386	CcSEcCtD
Dexrazoxane—Haemorrhage—Capecitabine—esophageal cancer	0.0033	0.00384	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.0033	0.00383	CcSEcCtD
Dexrazoxane—Discomfort—Cisplatin—esophageal cancer	0.00328	0.00381	CcSEcCtD
Dexrazoxane—Oedema peripheral—Capecitabine—esophageal cancer	0.00325	0.00378	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Capecitabine—esophageal cancer	0.00324	0.00377	CcSEcCtD
Dexrazoxane—Breast disorder—Methotrexate—esophageal cancer	0.00321	0.00373	CcSEcCtD
Dexrazoxane—Infection—Cisplatin—esophageal cancer	0.00316	0.00367	CcSEcCtD
Dexrazoxane—Nervous system disorder—Cisplatin—esophageal cancer	0.00312	0.00363	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Cisplatin—esophageal cancer	0.00311	0.00362	CcSEcCtD
Dexrazoxane—Skin disorder—Cisplatin—esophageal cancer	0.00309	0.00359	CcSEcCtD
Dexrazoxane—Cardiac disorder—Capecitabine—esophageal cancer	0.00306	0.00356	CcSEcCtD
Dexrazoxane—Anorexia—Cisplatin—esophageal cancer	0.00303	0.00353	CcSEcCtD
Dexrazoxane—Angiopathy—Capecitabine—esophageal cancer	0.00299	0.00348	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Capecitabine—esophageal cancer	0.00297	0.00346	CcSEcCtD
Dexrazoxane—Alopecia—Capecitabine—esophageal cancer	0.00292	0.00339	CcSEcCtD
Dexrazoxane—Pancytopenia—Methotrexate—esophageal cancer	0.00292	0.00339	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.0029	0.00337	CcSEcCtD
Dexrazoxane—Mental disorder—Capecitabine—esophageal cancer	0.00289	0.00336	CcSEcCtD
Dexrazoxane—Erythema—Capecitabine—esophageal cancer	0.00287	0.00334	CcSEcCtD
Dexrazoxane—Malnutrition—Capecitabine—esophageal cancer	0.00287	0.00334	CcSEcCtD
Dexrazoxane—Neutropenia—Methotrexate—esophageal cancer	0.00287	0.00334	CcSEcCtD
Dexrazoxane—Dyspnoea—Cisplatin—esophageal cancer	0.00284	0.0033	CcSEcCtD
Dexrazoxane—Decreased appetite—Cisplatin—esophageal cancer	0.00277	0.00322	CcSEcCtD
Dexrazoxane—Pneumonia—Methotrexate—esophageal cancer	0.00275	0.0032	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00275	0.00319	CcSEcCtD
Dexrazoxane—Infestation—Methotrexate—esophageal cancer	0.00274	0.00318	CcSEcCtD
Dexrazoxane—Infestation NOS—Methotrexate—esophageal cancer	0.00274	0.00318	CcSEcCtD
Dexrazoxane—Depression—Methotrexate—esophageal cancer	0.00273	0.00317	CcSEcCtD
Dexrazoxane—Pain—Cisplatin—esophageal cancer	0.00272	0.00316	CcSEcCtD
Dexrazoxane—Tremor—Capecitabine—esophageal cancer	0.00269	0.00313	CcSEcCtD
Dexrazoxane—Stomatitis—Methotrexate—esophageal cancer	0.00267	0.0031	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Capecitabine—esophageal cancer	0.00267	0.0031	CcSEcCtD
Dexrazoxane—Anaemia—Capecitabine—esophageal cancer	0.00266	0.00309	CcSEcCtD
Dexrazoxane—Feeling abnormal—Cisplatin—esophageal cancer	0.00262	0.00305	CcSEcCtD
Dexrazoxane—Malaise—Capecitabine—esophageal cancer	0.00259	0.00301	CcSEcCtD
Dexrazoxane—Syncope—Capecitabine—esophageal cancer	0.00258	0.003	CcSEcCtD
Dexrazoxane—Leukopenia—Capecitabine—esophageal cancer	0.00257	0.00299	CcSEcCtD
Dexrazoxane—Agranulocytosis—Methotrexate—esophageal cancer	0.00255	0.00297	CcSEcCtD
Dexrazoxane—Loss of consciousness—Capecitabine—esophageal cancer	0.00253	0.00294	CcSEcCtD
Dexrazoxane—Body temperature increased—Cisplatin—esophageal cancer	0.00251	0.00292	CcSEcCtD
Dexrazoxane—Cough—Capecitabine—esophageal cancer	0.00251	0.00292	CcSEcCtD
Dexrazoxane—Haemoglobin—Methotrexate—esophageal cancer	0.00247	0.00287	CcSEcCtD
Dexrazoxane—Haemorrhage—Methotrexate—esophageal cancer	0.00246	0.00286	CcSEcCtD
Dexrazoxane—Myalgia—Capecitabine—esophageal cancer	0.00245	0.00284	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00243	0.00282	CcSEcCtD
Dexrazoxane—Discomfort—Capecitabine—esophageal cancer	0.00242	0.00281	CcSEcCtD
Dexrazoxane—Dry mouth—Capecitabine—esophageal cancer	0.00239	0.00278	CcSEcCtD
Dexrazoxane—Infection—Capecitabine—esophageal cancer	0.00233	0.00271	CcSEcCtD
Dexrazoxane—Shock—Capecitabine—esophageal cancer	0.00231	0.00268	CcSEcCtD
Dexrazoxane—Nervous system disorder—Capecitabine—esophageal cancer	0.0023	0.00267	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Capecitabine—esophageal cancer	0.0023	0.00267	CcSEcCtD
Dexrazoxane—Asthenia—Cisplatin—esophageal cancer	0.00228	0.00265	CcSEcCtD
Dexrazoxane—Cardiac disorder—Methotrexate—esophageal cancer	0.00228	0.00265	CcSEcCtD
Dexrazoxane—Skin disorder—Capecitabine—esophageal cancer	0.00228	0.00265	CcSEcCtD
Dexrazoxane—Anorexia—Capecitabine—esophageal cancer	0.00224	0.0026	CcSEcCtD
Dexrazoxane—Angiopathy—Methotrexate—esophageal cancer	0.00223	0.00259	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Methotrexate—esophageal cancer	0.00221	0.00257	CcSEcCtD
Dexrazoxane—Diarrhoea—Cisplatin—esophageal cancer	0.00218	0.00253	CcSEcCtD
Dexrazoxane—Alopecia—Methotrexate—esophageal cancer	0.00217	0.00252	CcSEcCtD
Dexrazoxane—Mental disorder—Methotrexate—esophageal cancer	0.00215	0.0025	CcSEcCtD
Dexrazoxane—Erythema—Methotrexate—esophageal cancer	0.00214	0.00249	CcSEcCtD
Dexrazoxane—Malnutrition—Methotrexate—esophageal cancer	0.00214	0.00249	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00214	0.00248	CcSEcCtD
Dexrazoxane—Insomnia—Capecitabine—esophageal cancer	0.00212	0.00247	CcSEcCtD
Dexrazoxane—Dyspnoea—Capecitabine—esophageal cancer	0.00209	0.00243	CcSEcCtD
Dexrazoxane—Decreased appetite—Capecitabine—esophageal cancer	0.00204	0.00237	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00202	0.00235	CcSEcCtD
Dexrazoxane—Vomiting—Cisplatin—esophageal cancer	0.00202	0.00235	CcSEcCtD
Dexrazoxane—Fatigue—Capecitabine—esophageal cancer	0.00202	0.00235	CcSEcCtD
Dexrazoxane—Pain—Capecitabine—esophageal cancer	0.00201	0.00233	CcSEcCtD
Dexrazoxane—Constipation—Capecitabine—esophageal cancer	0.00201	0.00233	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Methotrexate—esophageal cancer	0.00198	0.00231	CcSEcCtD
Dexrazoxane—Anaemia—Methotrexate—esophageal cancer	0.00198	0.0023	CcSEcCtD
Dexrazoxane—Feeling abnormal—Capecitabine—esophageal cancer	0.00193	0.00225	CcSEcCtD
Dexrazoxane—Malaise—Methotrexate—esophageal cancer	0.00193	0.00224	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00192	0.00223	CcSEcCtD
Dexrazoxane—Leukopenia—Methotrexate—esophageal cancer	0.00191	0.00223	CcSEcCtD
Dexrazoxane—Nausea—Cisplatin—esophageal cancer	0.00189	0.0022	CcSEcCtD
Dexrazoxane—Cough—Methotrexate—esophageal cancer	0.00187	0.00217	CcSEcCtD
Dexrazoxane—Urticaria—Capecitabine—esophageal cancer	0.00186	0.00217	CcSEcCtD
Dexrazoxane—Abdominal pain—Capecitabine—esophageal cancer	0.00185	0.00216	CcSEcCtD
Dexrazoxane—Body temperature increased—Capecitabine—esophageal cancer	0.00185	0.00216	CcSEcCtD
Dexrazoxane—Myalgia—Methotrexate—esophageal cancer	0.00182	0.00212	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00181	0.0021	CcSEcCtD
Dexrazoxane—Discomfort—Methotrexate—esophageal cancer	0.0018	0.00209	CcSEcCtD
Dexrazoxane—Infection—Methotrexate—esophageal cancer	0.00173	0.00202	CcSEcCtD
Dexrazoxane—Nervous system disorder—Methotrexate—esophageal cancer	0.00171	0.00199	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Methotrexate—esophageal cancer	0.00171	0.00199	CcSEcCtD
Dexrazoxane—Skin disorder—Methotrexate—esophageal cancer	0.0017	0.00197	CcSEcCtD
Dexrazoxane—Asthenia—Capecitabine—esophageal cancer	0.00168	0.00196	CcSEcCtD
Dexrazoxane—Anorexia—Methotrexate—esophageal cancer	0.00166	0.00193	CcSEcCtD
Dexrazoxane—Pruritus—Capecitabine—esophageal cancer	0.00166	0.00193	CcSEcCtD
Dexrazoxane—Diarrhoea—Capecitabine—esophageal cancer	0.0016	0.00187	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00159	0.00185	CcSEcCtD
Dexrazoxane—Insomnia—Methotrexate—esophageal cancer	0.00158	0.00184	CcSEcCtD
Dexrazoxane—Dyspnoea—Methotrexate—esophageal cancer	0.00156	0.00181	CcSEcCtD
Dexrazoxane—Somnolence—Methotrexate—esophageal cancer	0.00155	0.0018	CcSEcCtD
Dexrazoxane—Dizziness—Capecitabine—esophageal cancer	0.00155	0.0018	CcSEcCtD
Dexrazoxane—Decreased appetite—Methotrexate—esophageal cancer	0.00152	0.00176	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00151	0.00175	CcSEcCtD
Dexrazoxane—Fatigue—Methotrexate—esophageal cancer	0.00151	0.00175	CcSEcCtD
Dexrazoxane—Pain—Methotrexate—esophageal cancer	0.00149	0.00174	CcSEcCtD
Dexrazoxane—Vomiting—Capecitabine—esophageal cancer	0.00149	0.00173	CcSEcCtD
Dexrazoxane—Headache—Capecitabine—esophageal cancer	0.00147	0.00171	CcSEcCtD
Dexrazoxane—Feeling abnormal—Methotrexate—esophageal cancer	0.00144	0.00167	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00143	0.00166	CcSEcCtD
Dexrazoxane—Nausea—Capecitabine—esophageal cancer	0.00139	0.00162	CcSEcCtD
Dexrazoxane—Urticaria—Methotrexate—esophageal cancer	0.00139	0.00161	CcSEcCtD
Dexrazoxane—Abdominal pain—Methotrexate—esophageal cancer	0.00138	0.0016	CcSEcCtD
Dexrazoxane—Body temperature increased—Methotrexate—esophageal cancer	0.00138	0.0016	CcSEcCtD
Dexrazoxane—Asthenia—Methotrexate—esophageal cancer	0.00125	0.00146	CcSEcCtD
Dexrazoxane—Pruritus—Methotrexate—esophageal cancer	0.00124	0.00144	CcSEcCtD
Dexrazoxane—Diarrhoea—Methotrexate—esophageal cancer	0.00119	0.00139	CcSEcCtD
Dexrazoxane—Dizziness—Methotrexate—esophageal cancer	0.00115	0.00134	CcSEcCtD
Dexrazoxane—Vomiting—Methotrexate—esophageal cancer	0.00111	0.00129	CcSEcCtD
Dexrazoxane—Headache—Methotrexate—esophageal cancer	0.00109	0.00127	CcSEcCtD
Dexrazoxane—Nausea—Methotrexate—esophageal cancer	0.00104	0.00121	CcSEcCtD
